An AllTrials project

NCT06683508: An ongoing trial by Eli Lilly and Company

This trial is ongoing. It must report results 1 year, 4 months from now.

Full data

Full entry on ClinicalTrials.gov NCT06683508
Title A Phase 2, Parallel-Group, Double-Blind Study to Investigate Weight Management With LY3549492 Once Daily Compared With Placebo in Adult Participants With Obesity or Overweight
Results Status Ongoing
ACT or pACT? This is what FDAAA officially calls an "Applicable Clinical Trial"
Start date Nov. 13, 2024
Completion date April 30, 2026
Required reporting date April 30, 2027, midnight
Actual reporting date None
Date last checked at ClinicalTrials.gov Dec. 12, 2025
Days late None